Yi-Ding Chen (Yiding Chen)

中国科学家在线 ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Venues

Nature medicine

Nature communications

Cancer

AME case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Chunwei Xu, Zhanhong Chen, Yuanli Xia, Yanxia Shi, Peifen Fu, Yi-Ding Chen, Xian Wang, Lili Zhang, Hengyu Li, Wenyan Chen, Jianfei Fu, Liming Huang, Jingde Shu, Ouchen Wang, Weizhu Wu, Bojian Xie, Ting Wang, Weiping Zhang, Shurong Shen, Qun Li, Ting Luo, Bin Zhang, Yanru Xie, Hongxia Wang, Qian Wang, Wen-Xian Wang, Ziming Li, Zhengbo Song, Wenfeng Fang, Wen-Zhao Zhong, Yongchang Zhang, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Feng Wang, Rui Meng, Youcai Zhu, Lin Wang, Bing Wan, Dong Wang, Yue Hao, Jianya Zhou, Long Huang, Zhang Zhang, Donglai Lv, Meiyu Fang, Yuanzhi Lu, Lu Si, Yong Song, Xiaojia Wang
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China. Cancer (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Chunwei Xu, Zhanhong Chen, Yuanli Xia, Yanxia Shi, Peifen Fu, Yi-Ding Chen, Xian Wang, Lili Zhang, Hengyu Li, Wenyan Chen, Jianfei Fu, Liming Huang, Jingde Shu, Ouchen Wang, Weizhu Wu, Bojian Xie, Ting Wang, Weiping Zhang, Shurong Shen, Qun Li, Ting Luo, Bin Zhang, Yanru Xie, Hongxia Wang, Qian Wang, Wen-Xian Wang, Ziming Li, Zhengbo Song, Wenfeng Fang, Wen-Zhao Zhong, Yongchang Zhang, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Feng Wang, Rui Meng, Youcai Zhu, Lin Wang, Bing Wan, Dong Wang, Yue Hao, Jianya Zhou, Long Huang, Zhang Zhang, Donglai Lv, Meiyu Fang, Yuanzhi Lu, Lu Si, Yong Song, Xiaojia Wang
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China. Cancer 130 (S17) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine (2024)
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng, Jiuwei Cui, Hai-Bo Wang, Yongmei Yin, Xiao-Jia Wang, Xin Zhou, Yongsheng Wang, Gang Sun, Jingfen Wang, Lili Zhang, Jin Yang, Jun Qian, Min Yan, Xinlan Liu, Tienan Yi, Ying Cheng, Man Li, Aimin Zang, Shu-Sen Wang, Chuan Wang, Xinhong Wu, Jing Cheng, Hui Li, Ying Lin, Cuizhi Geng, Kangsheng Gu, Chunwei Xie, Huihua Xiong, Xiaohong Wu, Junlan Yang, Qingshan Li, Yi-Ding Chen, Fanfan Li, Anqin Zhang, Yongqiang Zhang, Yudong Wu, Jianyun Nie, Qiang Liu, Kun Wang, Xueli Mo, Lilin Chen, Yue-Yin Pan, Peifen Fu, Helong Zhang, Danmei Pang, Yuan Sheng, Yunwei Han, Hongxia Wang, Shundong Cang, Xianming Luo, Wenbo Yu, Rong Deng, Chaoqiang Yang, Patricia Keegan
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature medicine 30 (1) (2024)
Yao Jin, Jinglu Lu, Ting Zhang, Shenqiang Yan, Huihui Chen, Kun Zhang, Yi-Ding Chen, Jiao-Jiao Zhou
Leptomeningeal metastasis of breast cancer during neo-adjuvant chemotherapy in a 38-year-old woman: a case report. AME case reports 8 (2024)
Yao Jin, Jinglu Lu, Ting Zhang, Shenqiang Yan, Huihui Chen, Kun Zhang, Yi-Ding Chen, Jiao-Jiao Zhou
Leptomeningeal metastasis of breast cancer during neo-adjuvant chemotherapy in a 38-year-old woman: a case report. AME case reports 8 (2024)
Shaohua Zhang, Jianbin Li, Ruonan Xu, Qianjun Chen, Gang Sun, Ying Lin, Yali Cao, Yi-Ding Chen, Cuizhi Geng, Teng Yuee, Jianyun Nie, Xinzheng Li, Guiying Xu, Xinlan Liu, Feng Jin, Zhimin Fan, Ting Luo, Hong Liu, Fu-Sheng Wang, Zefei Jiang
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China. JMIR public health and surveillance 9 (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Yabing Zheng, Wen-Ming Cao, Xiying Shao, Yanxia Shi, Li Cai, Wenyan Chen, Jian Liu, Peng Shen, Yi-Ding Chen, Xian Wang, Huiping Li, Man Li, Zhanhong Chen, Xiao-Jia Wang
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature communications 14 (1) (2023)
Shijie Wu, Lina Qi, Huihui Chen, Kun Zhang, Jiapan He, Xianan Guo, Lu Shen, Yunxiang Zhou, Xi Zhong, Shu Zheng, Jiaojiao Zhou, Yi-Ding Chen
Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. NPJ breast cancer 8 (1) (2022)
Lesang Shen, Jun Zhou, Yi-Ding Chen, Jinhua Ding, Haiyan Wei, Jian Liu, Wenjie Xia, Bojian Xie, Xiaohong Xie, Xujun Li, Yuechu Dai, Guobing Zhang, Xia Qiu, Chao Li, Shanshan Sun, Wuzhen Chen, Dihe Gong, Hengyu Li, Jian Huang, Xia Jiang, Chao Ni
Treatment patterns, effectiveness, and patient-reported outcomes of palbociclib therapy in Chinese patients with advanced breast cancer: A multicenter ambispective real-world study. Cancer medicine 11 (22) (2022)
Jiahui Mou, Meijun Huang, Feifei Wang, Xiaoding Xu, Hanqi Xie, Henglei Lu, Mingyang Li, Yu Li, Weiwen Kong, Jing Chen, Ying Xiao, Yi-Ding Chen, Chaochen Wang, Jin Ren
HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis. Molecular cancer research : MCR 20 (12) (2022)
Huihui Chen, Shijie Wu, Jun Hu, Kun Zhang, Kai-Min Hu, Yuexin Lu, Jiapan He, Tao Pan, Yi-Ding Chen
Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning. Journal of oncology 2021 (2021)
Jiaojiao Zhou, Xuan Zhu, Shijie Wu, Jingxin Guo, Kun Zhang, Chunjing Xu, Huihui Chen, Yuxi Jin, Yuting Sun, Shu Zheng, Yi-Ding Chen
Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance. Cancer biology & medicine 17 (1) (2021)
Jiao-Jiao Zhou, Honglian Wang, Fangmeng Fu, Zhanwen Li, Qingjian Feng, Weizhu Wu, Yun Liu, Chuan Wang, Yi-Ding Chen
Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencing. Cancer 126 (14) (2020)
Jiao-Jiao Zhou, Qishan Chen, Yiheng Zou, Shu Zheng, Yi-Ding Chen
Stem Cells and Cellular Origins of Mammary Gland: Updates in Rationale, Controversies, and Cancer Relevance. Stem cells international 2019 (2019)
Mei Deng, Hui-Hui Chen, Xuan Zhu, Meng Luo, Kun Zhang, Chun-Jing Xu, Kai-Min Hu, Pu Cheng, Jiao-Jiao Zhou, Shu Zheng, Yi-Ding Chen
Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China. International journal of cancer 145 (6) (2019)
Huihui Chen, Wei Lu, Yixin Zhang, Xuan Zhu, Jiaojiao Zhou, Yi-Ding Chen
A Bayesian network meta-analysis of the efficacy of targeted therapies and chemotherapy for treatment of triple-negative breast cancer. Cancer medicine 8 (1) (2018)
Kun Zhang, Jiaojiao Zhou, Xuan Zhu, Meng Luo, Chunjing Xu, JieKai Yu, Mei Deng, Shu Zheng, Yi-Ding Chen
Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer. Breast cancer research and treatment 166 (3) (2017)

Yi-Ding Chen.css-eqlu8i{font-size:small;padding-left:4px;} (Yiding Chen)

Publication Activity (10 Years)

Top Topics

Top Venues

Yi-Ding Chen (Yiding Chen)